Aclarion AAQS

Que fait Aclarion ? Aclarion Inc, trading under the ticker ACON, is a healthcare technology company based in Broomfield, Colorado, with a focus on medical diagnostics. The company specializes in Magnetic Resonance Spectroscopy (MRS) and has developed a proprietary biomarker designed to optimize clinical treatments for patients with chronic low back pain. Aclarion's technology processes raw MRS data using signal processing software and an expert system to generate clear metabolic biomarkers. These biomarkers help physicians distinguish between painful and nonpainful lumbar discs. The company utilizes augmented intelligence in a post-processing algorithm to analyze and quantify biomarker data, producing individualized ratio metrics for each lumbar disc based on a normative data set. Aclarion went public via an IPO on April 22, 2022. The company employs seven full-time staff members. Its website is aclarion.com. Aclarion operates within the Health Care sector and Industry, targeting the optimization of treatment strategies for chronic low back pain through advanced diagnostic tools. Aclarion est l'une des entreprises les plus populaires sur Eulerpool.